Treatment Strategy for Stage I Testicular Germ Cell Tumor

HANDLE Web Site Open Access
  • Nakai, Yasutomo
    The Department of Urology, Osaka University Graduate School of Medicine
  • Nagahara, Akira
    The Department of Urology, Osaka University Graduate School of Medicine
  • Uemura, Motohide
    The Department of Urology, Osaka University Graduate School of Medicine
  • Takayama, Hitoshi
    The Department of Urology, Osaka University Graduate School of Medicine
  • Nonomura, Norio
    The Department of Urology, Osaka University Graduate School of Medicine

Bibliographic Information

Other Title
  • Stage I 精巣腫瘍の治療戦略
  • Stage Ⅰ セイソウ シュヨウ ノ チリョウ センリャク

Search this article

Abstract

Most stage I testicular germ cell tumors are curable by orchiectomy alone. However, some tumors recur and require subsequent treatment. The point for the management of stage I testicular germ cell tumors is how to reduce the recurrence rate by appropriate adjuvant treatment with less adverse events. The strategy for stage I seminoma and stage I nonseminoma is different. The adjuvant treatment options include radiotherapy and 1-2 courses of carboplatin for seminoma and retroperitoneal lymph node dissection (RPLND) and 1-2 courses of bleomycin, etoposide and cisplatin chemotherapy for nonseminoma. This review discusses recent literature on adjuvant treatment and updates the consensus for the management of stage I testicular germ cell tumor.

Journal

  • Hinyokika Kiyo

    Hinyokika Kiyo 58 (12), 715-720, 2012-12

    泌尿器科紀要刊行会

Keywords

Details 詳細情報について

Report a problem

Back to top